Navigation Links
SAGE Labs, Inc. Licenses CRISPR/Cas9 genome engineering technology from Caribou Biosciences, Inc.
Date:9/24/2013

ST. LOUIS, Sept. 24, 2013 /PRNewswire/ -- SAGE Labs, Inc., a leading provider of in vivo products, services and technologies in the field of genome engineering, announced today that it has entered into a partnership and licensing agreement with Caribou Biosciences, Inc. (Caribou Bio) for key intellectual property related to the CRISPR/Cas9 genome editing system.

Under the agreement, SAGE Labs will gain exclusive rights to Caribou Bio's intellectual property to produce and sell genetically engineered rats, and will gain non-exclusive rights for mouse and rabbit models.  The Cas9 system will complement SAGE's Zinc Finger Nuclease (ZFN) technology, allowing SAGE to offer customers access to novel animal models of human disease, as well as reduced turnaround times for its custom model creation platform, SAGEspeed®.

"SAGE Labs is the leader in creation of next-generation research models. As such, it is important to have access to key technologies needed to perform complex genome engineering projects," commented Dr. David Smoller, CEO of SAGE Labs. "Using Cas9 allows us to provide our customers with enhanced models that provide the most translational value for their research."

"We believe the Cas9 system will become very important in the creation of new models of human disease, both in vitro and in vivo," commented Dr. Rachel Haurwitz, CEO of Caribou Bio. "SAGE Labs' track record as a market leader in commercializing in vivo technologies will enable them to use Cas9-based engineering to bring innovative, high-quality engineered research models to the marketplace."

Please see www.sageresearchlabs.com for further details.

About SAGE Labs

SAGE® Labs is a world-class provider of next-generation research models and transgenic support services. Using proprietary platform technologies, such as Zinc Finger Nucleases (ZFN) and the CRISPR/Cas9 system for genome engineering, SAGE produces complex in vivo research models in half the time as models produced using conventional technologies. For more information, visit http://www.sageresearchlabs.com.

About Caribou Bio

Caribou Bio specializes in the research and development of technologies for cellular engineering and analysis. Caribou Bio's technologies are based on the unique capabilities of Cas enzymes from the CRISPR prokaryotic immune system. Caribou Bio's lead technology is the Cas9 enzyme, a highly efficient and easy to use genome editing platform that does not require unique protein development.

Media Contact:
Phil Simmons
(314) 313-7847
Phil.Simmons@sageresearchlabs.com

 


'/>"/>
SOURCE SAGE Labs, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. LABS, Inc. Earns AABB Accreditation for Donor Testing
2. LABS, Inc. Among Colorados Top Private Companies
3. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
4. Sigma Life Science Licenses CompoZr Zinc Finger Nuclease Technology to Horizon Discovery
5. Genomatica Licenses TeselaGen Software for DNA Design
6. Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer
7. SRI International Licenses Bed Bug Detection Technology to Redcoat, a Virginia-Based Start-Up Company
8. Personal Genome Diagnostics Inc. Licenses Genome-Mapping Technology from Johns Hopkins University and Expands Its Cancer Genome Analysis Business
9. Genomas Expands Personalized Medicine Business with Clinical Laboratory Licenses in New York, Florida, California
10. Syngenta Licenses Plant Sensory Systems' Technology
11. Bluechiip Licenses Its Technology in Deal with US Tech Company MiTeGen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2019)... ... August 27, 2019 , ... Modality Solutions , an ... promoted Consulting Engineer, Robert Battista, to Senior Consulting engineer. , In his new ... mentoring new engineers as well as the creation of additional business opportunities and ...
(Date:8/23/2019)... Fla. (PRWEB) , ... August 22, 2019 , ... ... explore new drug delivery modalities and is scheduled to broadcast 4Q/2019. Check your ... Science’s (Avro) state-of-the-art skin patches for generic drug delivery. Focusing on therapeutics for ...
(Date:8/14/2019)... ... 13, 2019 , ... Chata was founded in ... laboratories. After gaining a few significant clients, Lifecycle purchased the company with the ... of manufacturing processing solutions, including reagents for tissue processing. Chata quickly outgrew the ...
(Date:8/6/2019)... SAN DIEGO (PRWEB) , ... August 06, 2019 ... ... Science Marketing Radio (LSMR) have joined forces in launching the biweekly SDBN BUZZ ... its further growth. SDBN BUZZ podcast will also serve to promote the region ...
Breaking Biology Technology:
(Date:9/8/2019)... ... September 06, 2019 , ... ... and leading supplier of innovative human mesenchymal stem/stromal cell (hMSC) biomanufacturing systems, ... cord (hUC) MSC paired cell and media system designed for product development. ...
(Date:8/29/2019)... ... 29, 2019 , ... Advancements with Ted Danson announced today ... episode, which is scheduled to broadcast 1Q/2020. Check local listings for more information. ... surgical solutions for the treatment of patients suffering from spinal disorders. Traveling behind-the-scenes ...
(Date:8/27/2019)... ... 26, 2019 , ... Shoreline Biome , a microbiome research company that ... McKenzie as its CEO and Karen Woodward as its VP of Business Development. ... for its products and expand the company’s sales worldwide. , Prior to joining Shoreline ...
Breaking Biology News(10 mins):